Checkmate Pharmaceuticals

Checkmate Pharmaceuticals

Checkmate Pharmaceuticals

Checkmate Pharmaceuticals, a Cambridge, MA-based clinical stage biotechnology company with a novel approach to cancer immunotherapy.
Founded
2015
Raised
$134M
Follow us
Alexa global traffic share
Latest funding Show all
$85,000,000
Venture capital (Series C) - 2020
Omega Funds Longitude Capital Sectoral Asset Management +8
$22,000,000
Venture capital (Series C) - 2018
Team Size
1–10
Employees
$85,000,000 Venture capital (Series C)
FinSMEs , Pulse 2.0

Checkmate Pharmaceuticals Raises $85M in Series C Financing

$22,000,000 Venture capital (Series C)
FinSMEs

Checkmate Pharmaceuticals Closes $22M Financing

$27,000,000 Venture capital (Series B)
businesswire , PE HUB , ENDPOINTS NEWS

Checkmate Pharmaceuticals Secures $27 Million Series B Preferred Financing and Appoints Karen Brennan as Chief Operating...